Clinical trial
Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary…
NCT00469326 · University Hospital, Motol, Other · Completed
Key facts
| NCT number | NCT00469326 |
|---|---|
| Title | Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study |
| Official title | Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study |
| Acronym | TIPS |
| Lead sponsor | University Hospital, Motol, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | Atorvastatin |
| Enrollment | 200 |
| Start date | Apr 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | May 4, 2007 |
| Last update posted | Jan 27, 2009 |
| Countries | Czechia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: